“…Medical imaging is a promising source for biomarker development as it provides a macroscopic view of tissues of interest (O 'Connor et al, 2017) and has advantages of noninvasiveness, readily availability in clinical care, and repeatability (Lambin et al, 2017;Morin et al, 2018). CT (Caglar et al, 2012), MRI (Sato et al, 2012;Wang et al, 2021b), ultrasonography (Glaser and Stienecker, 2000), endoscopic ultrasonography (EUS) (Rajan et al, 2005), endoscopic ultrasound elastography (EUS-elastography) (Janssen and Papavassiliou, 2014), and endoscopic retrocholangiography (ERCP) (Anand et al, 1989;Hastier et al, 1998), etc., have been commonly used to assess the agerelated morphological changes of the human pancreas. Reduction of pancreatic volume, hardening of texture, and dilatation of the pancreatic ducts, as well as pancreatic lobulation (Sato et al, 2012) and pancreatic steatosis (Begovatz et al, 2015) are the main findings from these studies associated with aging, which are potential biomarkers for the macroscopic changes of pancreatic aging (Table S15 in Supporting Information).…”